Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of ...

More than 31 million people in the U.S. live with eczema, a chronic skin condition that can disrupt daily life yet continues ...

Findings showed Staloral Birch, compared with placebo, demonstrated a 41% improvement in the ARC total combined score during the second pollen season. Topline data were announced from a phase 3b trial ...

Women across the country can now access the morning-after pill for free from their pharmacy without needing a GP appointment.

Discover what causes red palms, including certain skin conditions and deeper medical issues, and learn when you should call a doctor about this symptom.

At 49, Derek Wilks was a picture of health. The accountant from Purley, in south London, had run marathons around the world ...

Condensation on windows is a common problem in Irish homes during the winter months, but there are some simple ways to ...

The government shutdown is exacting a heavy mental toll on the nation's military families, leaving them not knowing from week ...

Across the Atlantic, a brown, sprawling presence is testing coasts, economies, and patience as warmer months return again. New satellite measurements and ...

In the WAYFINDER trial, tezepelumab reduced oral corticosteroid use in patients with severe asthma, with well-controlled ...

Clinics licensing MERT have claimed that their trademarked version of the treatment can also produce “miraculous results” in ...